Literature DB >> 4089535

Primary plasma cell leukaemia: immunological and ultrastructural studies in 6 cases.

A Parreira, D S Robinson, J V Melo, M Ayliffe, S Ball, U Hegde, A Baughan, S Fairhead, J G Talavera, J A Katzmann.   

Abstract

The clinical and laboratory studies of 6 patients with primary plasma cell leukaemia are described. The leukaemic cells had a variable morphology, ranging from lymphoplasmacytic and mature plasma cells to poorly differentiated blasts. The neoplastic plasma cells had a characteristic phenotype: they were positive for CyIg and the McAb OKT10 and Ri-3, and did not express the B-cell antigens Ia, B1 and B4. Ultrastructural studies confirmed the plasma cell nature of the leukaemic cells and showed the presence of a meshwork of cytoplasmic fibrils in 50 to 90% of the neoplastic cells from all cases. The distinct ultrastructural and immunological features of PCL described in this study will help the diagnosis and further characterisation of this disease entity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4089535     DOI: 10.1111/j.1600-0609.1985.tb02830.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  5 in total

1.  Non-secretory multiple myeloma presenting as primary plasma cell leukaemia.

Authors:  A Sureda; J R Pais; J Pascual; M A Pérez Vaquero; J C Hernando
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

2.  Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  J Clin Pathol       Date:  1989-06       Impact factor: 3.411

3.  The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement.

Authors:  J V Melo; L Foroni; V Brito-Babapulle; L Luzzatto; D Catovsky
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

Review 4.  Immunophenotyping in the diagnosis of chronic lymphoproliferative disorders. General Haematology Task Force of BCSH.

Authors: 
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

Review 5.  Immunotherapies targeting CD38 in Multiple Myeloma.

Authors:  Djordje Atanackovic; Mary Steinbach; Sabarinath Venniyil Radhakrishnan; Tim Luetkens
Journal:  Oncoimmunology       Date:  2016-08-05       Impact factor: 8.110

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.